Tuesday, April 26, 2011

Innovation: Robotic Coronary Angioplasty

































J Am Coll Cardiol Intv, 2011; 4:460-465,

First-in-Human Evaluation of a Novel Robotic-Assisted Coronary Angioplasty System

Juan F. Granada, MD*,,*, Juan A. Delgado, MD, Maria Paola Uribe, MSCE, Andres Fernandez, MD, Guillermo Blanco, MD, Martin B. Leon, MD, Giora Weisz, MD
* Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, New York, New York Corbic Research Institute, Envigado, Colombia Corbic Medical Center, Envigado, Columbia New York Presbyterian Hospital, Columbia University Medical Center, New York, New York (Email: jgranada@crf.org)

Background: A remote-control, robotic-assisted angioplasty system is under development to address some of the procedural challenges and occupational hazards associated with traditional PCI.

Methods:

CorPath 200 robotic system (Corindus, Inc., Natick, Massachusetts) consists of a remote cockpit & a multicomponent bedside unit that enables the operator to advance, retract, and rotate guidewires and rapid exchange catheters. The primary endpoint was device clinical success (30% residual stenosis) without in-hospital major adverse cardiac events.


Technical success was defined as the ability of the system to complete all the planned angioplasty steps on the basis of procedural segments. Patients were followed up to 30 days after angioplasty procedure.

Results: A total of 8 patients were enrolled in the study. The primary endpoint was achieved in all patients (100%). The technical success of the robotic system was 97.9% in completing 47 of 48 planned steps. There were no device- or procedure-related complications and no in-hospital or 30-day major adverse cardiac events. The operators rated the robotic system performances as equal to or better than manual procedures in 97.5% of the cases. The operator radiation exposure was 97% lower than the levels found at the standard table position.

Conclusions: Early clinical experience with a robotic-assisted angioplasty system demonstrated feasibility, safety, and procedural effectiveness comparable to manual operation. In addition, the total operator exposure to radiation was significantly low. A larger study is warranted to verify the safety and effectiveness of robotic-assisted percutaneous coronary intervention.

1 comment:


  1. I started on COPD Herbal treatment from Ultimate Health Home, the treatment worked incredibly for my lungs condition. I used the herbal treatment for almost 4 months, it reversed my COPD. My severe shortness of breath, dry cough, chest tightness gradually disappeared. Reach Ultimate Health Home via their email at ultimatehealthhome@gmail.com . I can breath much better and It feels comfortable!

    ReplyDelete